132 related articles for article (PubMed ID: 27748158)
1. Mobilising a global response to hepatitis: Lessons learned from the HIV movement.
Taaffe J; Wilson D
Glob Public Health; 2018 Apr; 13(4):473-488. PubMed ID: 27748158
[TBL] [Abstract][Full Text] [Related]
2. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
[TBL] [Abstract][Full Text] [Related]
3. Hep-CORE: a cross-sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017.
Lazarus JV; Stumo SR; Harris M; Hendrickx G; Hetherington KL; Maticic M; Jauffret-Roustide M; Tallada J; Simojoki K; Reic T; Safreed-Harmon K;
J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25052. PubMed ID: 29633562
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology, responses, and way forward: the silent epidemic of viral hepatitis and HIV coinfection in Vietnam.
Sereno L; Mesquita F; Kato M; Jacka D; Nguyen TT; Nguyen TN
J Int Assoc Physicians AIDS Care (Chic); 2012; 11(5):311-20. PubMed ID: 22828983
[TBL] [Abstract][Full Text] [Related]
5. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission.
Cooke GS; Andrieux-Meyer I; Applegate TL; Atun R; Burry JR; Cheinquer H; Dusheiko G; Feld JJ; Gore C; Griswold MG; Hamid S; Hellard ME; Hou J; Howell J; Jia J; Kravchenko N; Lazarus JV; Lemoine M; Lesi OA; Maistat L; McMahon BJ; Razavi H; Roberts T; Simmons B; Sonderup MW; Spearman CW; Taylor BE; Thomas DL; Waked I; Ward JW; Wiktor SZ;
Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):135-184. PubMed ID: 30647010
[TBL] [Abstract][Full Text] [Related]
6. [Private companies: an opportunity for hepatitis B virus (HBV) prevention and care in Ivory Coast in the wake of HIV/AIDS?].
Bekelynck A
Bull Soc Pathol Exot; 2015 Feb; 108(1):57-62. PubMed ID: 25407333
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis and follow-up after possible exposure to HIV, hepatitis B virus, and hepatitis C virus outside hospital: evaluation of policy 2000-3.
Sonder GJ; Regez RM; Brinkman K; Prins JM; Mulder JW; Spaargaren J; Coutinho RA; van den Hoek A
BMJ; 2005 Apr; 330(7495):825-9. PubMed ID: 15817550
[TBL] [Abstract][Full Text] [Related]
8. Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis.
Lazarus JV; Lundgren J; Casabona J; Wiessing L; Matheï C; Vickerman P; Prins M; Kretzschmar M; Kantzanou M; Giraudon I; Ferri M; Griffiths P; Harris M; Walker M; Chavdarova L; Schatz E; Schiffer K; Kools J; Farell J; Mendão L
BMC Infect Dis; 2014; 14 Suppl 6(Suppl 6):S18. PubMed ID: 25252919
[No Abstract] [Full Text] [Related]
9. Global hepatitis C elimination: an investment framework.
Pedrana A; Howell J; Scott N; Schroeder S; Kuschel C; Lazarus JV; Atun R; Baptista-Leite R; 't Hoen E; Hutchinson SJ; Aufegger L; Peck R; Sohn AH; Swan T; Thursz M; Lesi O; Sharma M; Thwaites J; Wilson DP; Hellard M
Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):927-939. PubMed ID: 32730786
[TBL] [Abstract][Full Text] [Related]
10. [Development of prevention programmes for HIV, hepatitis and sexually transmitted infections among migrants consulting in the doctors of the World French centers].
Pauti MD; Simonnot N; Estecahandy P
Med Mal Infect; 2008 Sep; 38(9):495-9. PubMed ID: 18706782
[TBL] [Abstract][Full Text] [Related]
11. The urgent need for HIV and hepatitis prevention in drug treatment programs in Hungary.
Gyarmathy VA; Rácz J; Neaigus A; Ujhelyi E
AIDS Educ Prev; 2004 Jun; 16(3):276-87. PubMed ID: 15237056
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B and C in the context of HIV disease: implications for incarcerated populations.
Spaulding AC; Lally M; Rich JD; Dieterich DT
AIDS Read; 1999 Oct; 9(7):481-91. PubMed ID: 12737140
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B and hepatitis C in southeast and southern Asia: challenges for governments.
Wait S; Kell E; Hamid S; Muljono DH; Sollano J; Mohamed R; Shah S; Mamun-Al-Mahtab ; Abbas Z; Johnston J; Tanwandee T; Wallace J
Lancet Gastroenterol Hepatol; 2016 Nov; 1(3):248-255. PubMed ID: 28404097
[TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness of introducing nucleic acid testing to test for hepatitis B, hepatitis C, and human immunodeficiency virus among blood donors in Sweden.
Davidson T; Ekermo B; Gaines H; Lesko B; Åkerlind B
Transfusion; 2011 Feb; 51(2):421-9. PubMed ID: 20849409
[TBL] [Abstract][Full Text] [Related]
15. Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study.
Ruan Y; Qin G; Yin L; Chen K; Qian HZ; Hao C; Liang S; Zhu J; Xing H; Hong K; Shao Y
AIDS; 2007 Dec; 21 Suppl 8():S39-46. PubMed ID: 18172390
[TBL] [Abstract][Full Text] [Related]
16. [Hepatitis B and hepatitis C, a high stake for public health: how to reconcile health cost control and public health expenses?].
Allerg Immunol (Paris); 1997 Sep; 29(7):215-8. PubMed ID: 9432191
[No Abstract] [Full Text] [Related]
17. [Press debates, scandals, and implementation of a prevention policy: on hepatitis C in Egypt].
Radi S
Rev Epidemiol Sante Publique; 2006 Jul; 54 Spec No 1():1S45-1S52. PubMed ID: 17073129
[TBL] [Abstract][Full Text] [Related]
18. WORLD HEPATITIS SUMMIT HARNESSES GLOBAL MOMENTUM TO ELIMINATE VIRAL HEPATITIS.
Cent Eur J Public Health; 2015 Sep; 23(3):272. PubMed ID: 26618210
[No Abstract] [Full Text] [Related]
19. Progress towards elimination goals for viral hepatitis.
Cox AL; El-Sayed MH; Kao JH; Lazarus JV; Lemoine M; Lok AS; Zoulim F
Nat Rev Gastroenterol Hepatol; 2020 Sep; 17(9):533-542. PubMed ID: 32704164
[TBL] [Abstract][Full Text] [Related]
20. Global epidemiology and burden of hepatitis C.
Ray Kim W
Microbes Infect; 2002 Oct; 4(12):1219-25. PubMed ID: 12467763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
